NeoraVision Vision
Precise. Elegant. Scalable.
One technology.
Multiple indications.
Presbyopia is a physiological insufficiency of optical accommodation associated with the aging of the eye, it results in progressively worsening ability to focus clearly on close objects.
Addressing presbyopia as our first indication
Normal Vision
Clear vision at
all distances;
no refractive error
Age of diagnosis:
Any age
Presbyopia
Age-related deterioration
in near vision
Age of diagnosis:
Mid-40s
Normal Vision
Clear vision at
all distances;
no refractive error
Age of diagnosis:
Any age
Presbyopia
Age-related deterioration
in near vision
Age of diagnosis:
Mid-40s
Myopia &
Myopia Control
Nearsightedness; distant objects
appear blurry
Age of diagnosis:
Childhood
to adolescence
Hyperopia
Farsightedness; nearby objects
appear blurry
Age of diagnosis:
Any age
Astigmatism
Blurred vision
due to irregular
cornea
Age of diagnosis:
Any age
The Unmet Need
Lack of a durable, spectacle-free solution for
pre-cataract presbyopia patients
The Solution
NeoraVision's technology is designed to deliver multi-year spectacle independence while preserving corneal shape and avoiding interocular surgery
Unique Value Proposition
Confidence & peace of mind: an adjustable and reversible procedure
Unique Value Proposition
Eliminates the need for reading glasses
Access to Choice:
Temporary or
long-lasting solution
Restoring near vision while preserving
distance vision
Micro-Invasive, Extraocular:
Crystalline lens and
corneal integrity preserved
Add-on kit designed
for use with
existing lasers
Keeps future options open:
Monofocal / EDOF / multifocal IOLs
A Team That Has
Done This Before
Daria Lemann-Blumenthal, LL.B., EMBA
CEO
Former CEO and Co-Founder, BELKIN Vision
Acquired by Alcon for $466M
Arik Hybloom, CPA
CFO
Former CFO, BELKIN Vision
Director at Make a Wish
Prof. David Smadja, MD
Co-founder & CMO
Chair of the Innovation Committee of the International Society of Refractive Surgery
Keren Reuveni, M.Sc.
Clinical Affairs Director
MedTech Clinical Affairs Professional
Dana Leitman, M.Sc., EMBA
VP QA/RA
Former Head of APAC
Arcondis Group
Yifat Harel, PhD
Bio-Chemical Scientist
Research Lab Manager,
Bar Ilan University
Eran Kaplan, M.Sc.
CTO
Former VP R&D and CEO, IOPtima
Jay Stark, MBA
Commercial Strategy Lead
Former leader at Alcon (18 years)
Board of Directors
Assaf Barnea
Chairman of the Board
Managing Partner
Sanara Ventures
Yoav Shaked
Venture Partner, Sanara
Partner, Sequoia Capital
Rick Heinick
Founder, Solo VC
Eli Yered
Partner and CFO
Sanara Ventures
Prof. David Smadja, MD
Co-founder & CMO
Prof. Zeev Zalevsky PhD
VP for Academia-Industry Relations, Bar Ilan University
NeoraVision Co-founder
Medical Advisory Board
Arthur Cummings, MD
Chairman
Medical Director of Wellington Eye Clinic, Dublin, Ireland.
Member of the Board of Directors, Alcon
Ronald Krueger, MD
MSE
McGaw, Professor and Chair of the Department of Ophthalmology and Visual Sciences at the University of Nebraska Medical Center, USA, and the Director of the Truhlsen Eye Institute
Vance Thompson, MD
Founder of Vance Thompson Vision, Professor of Ophthalmology in the Sanford School of Medicine, University of South Dakota, USA
Damien Gatinel, MD
PhD
Head of the Anterior Segment & Refractive Surgery Department at the Rothschild Foundation, Paris, France
Sally Tucker PhD,
MCOptom
Optometrist with a proven track record in clinical affairs execution, in start-ups and international top 30 healthcare companies